
SPGI · NYSE
Consensus is Buy across 21 analysts, with a mean price target of $525. The supplied consensus does not provide low or high targets, so target clustering and the width of the spread cannot be assessed. No named analyst or firm is identified as the most bullish or least bullish, and no analyst target or rating revisions are reported for the past week. Consequently, the substantive disagreement behind the target dispersion cannot be established from the evidence. The available commentary instead centers on whether SPGI's second-quarter earnings miss represents genuine weakness despite 10% revenue growth, rather than on a documented change in analyst sentiment.